McDonnell Boehnen Hulbert & Berghoff LLP partner Dr. Kevin E. Noonan is quoted in an October 3, 2014 edition of Law360.com in an article entitled, “Fed. Circ. To Eye Gene Patent Ruling’s Reach In Myriad Case.” The Federal Circuit will hear arguments Monday in a case that may clarify whether the U.S. Supreme Court’s decision that Myriad Genetics Inc. cannot patent human genes invalidates other inventions involving natural products, as Myriad appeals the denial of an injunction in a case over its cancer-testing patents. View the article